je.st
news
Tag: designation
Active Adults Realty's Debbie Shearer, REALTOR Earns Seniors Real Estate Specialist Designation
2014-01-18 03:10:24| Real Estate - Topix.net
Kathy Sperl-Bell, Broker and Bill Bell, REALTORA and co-owners of Active Adults Realty located at 1504 Savannah Road in Lewes are pleased to announce that Debbie Shearer, REALTORA has successfully completed the Seniors Real Estate Specialist Designation Course.
Tags: real
estate
active
real estate
Northrop Grumman's Global Hawk Boasts Best Safety Record Designation
2014-01-14 06:00:00| Industrial Newsroom - All News for Today
SAN DIEGO – Northrop Grumman Corporation's (NYSE: NOC) Global Hawk Unmanned Aerial System (UAS) has been designated as the platform with the best safety record in the U.S. Air Force in 2013. Detachment 1 of the 69th Reconnaissance Group contributed to that designation as they maintained exceptional vigilance during all Global Hawk aircraft operations, garnering a perfect safety record and a Commander's Flight Safety Award during the 4th quarter of fiscal year 2013. The team increased ...This story is related to the following:Unmanned Aerial Vehicles (UAV) | Aircraft
Tags: global
record
safety
designation
Gilead's Sovaldi Awarded Breakthrough Designation
2014-01-05 20:08:18| Biotech - Topix.net
A number of drugs currently in development were approved for a "breakthrough therapy" designation from the Food and Drug Administration this past year, with Gilead Sciences' Sovaldi, a medicine used to treat hepatitis C, leading the group, reports Bloomberg .
Tags: awarded
designation
breakthrough
designation awarded
NPS Pharmaceuticals Receives Orphan Drug Designation for Natpara in Europe
2014-01-04 07:51:40| Biotech - Topix.net
NPS Pharmaceuticals, Inc. , a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug designation to Natpara for the treatment of hypoparathyroidism.
Tags: europe
drug
receives
designation
Athersys' MultiStem(R) Stem Cell Therapy Receives Orphan Drug Designation In Europe For Prevention Of Graft-Versus-Host Disease
2013-12-30 06:10:10| drugdiscoveryonline Home Page
Athersys, Inc. (Nasdaq:ATHX) announced today that the Committee for Orphan Medicinal Products of the European Medicines Agency (EMA) has issued a positive opinion (EMA/OD/146/13) for the Company's allogeneic, multipotent adult progenitor cell, or MultiStem® therapy, for the prevention of graft-versus-host disease (GvHD)
Tags: europe
cell
drug
disease
Sites : [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] next »